Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Naltrexone And Bupropion

A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects

Orexigen Therapeutics, Inc · Phase 3 · Completed · Enrollment 1742

NCT00532779

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

X axis: threshold category. Y axis: participants reaching threshold, %.

39.4947.9816.44
≥5%
20.1724.637.44
≥10%
≥15%
≥20%
Show as table
Arm≥5%≥10%≥15%≥20%
NB1639.49%20.17%n/rn/r
NB3247.98%24.63%n/rn/r
Placebo16.44%7.44%n/rn/r

Not shown

Every selected arm is drawn.